Media kit
Logos and background for journalists writing about Saibogen.
Updated Nov. 9, 2026
Press release · Nov. 9, 2026
Hologen and Sysmex establish Saibogen, a joint venture using AI to turn routine blood test data into clinical intelligence
Fact sheet
Saibogen at a glance
The company, the numbers, how it works and who it serves, on one page.
About Saibogen
Short version
Saibogen is a blood intelligence company and a joint venture of Hologen and Sysmex Corporation. It applies Hologen’s Large Medicine Models to the data that Sysmex hematology analyzers capture in every routine blood count, giving researchers and clinicians a richer view of each patient with no new instruments, reagents or samples. Saibogen is based in Singapore.
Full version, as in the release
Saibogen is a blood intelligence company working toward a world where a routine blood test is one of the most informative in medicine. A joint venture of Hologen and Sysmex Corporation, Saibogen builds on Hologen’s Large Medicine Models to learn from the data that Sysmex hematology analyzers capture in every test and will deliver its products as software through Sysmex’s hematology analyzers, with no new instruments, reagents or samples. Saibogen is based in Singapore. Learn more at Saibogen.com.
Founding partners
Terms of use
These materials are provided for editorial coverage of Saibogen. Please use the logos as supplied, without recoloring, redrawing or altering them.